Lataa...
Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
Use of argatroban as an alternative to heparin during cardiopulmonary bypass (CPB) in patients with heparin-induced thrombocytopenia has gained some attention in the past two decades. Dosing of argatroban during CPB is complex due to lack of complete understanding of its pharmacokinetic profile and...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3275940/ https://ncbi.nlm.nih.gov/pubmed/22345956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-9185.92458 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|